Soluble CD146 reflects altered endothelial and metabolic homeostasis in peripheral artery disease

Haizam Oubari1,2, Julien Labreuche3, Charlotte Reytier4

  • 1Center for Engineering in Medicine and Surgery, Department of Surgery, Harvard Medical School, Massachusetts General Hospital, États-Unis, Boston, MA, États-Unis d'Amérique.

Angiogenesis
|June 9, 2026
PubMed
Abstract

Insights

Lower levels of soluble CD146 (sCD146) are associated with Peripheral Arterial Disease (PAD). This finding suggests sCD146 may be a novel diagnostic biomarker for PAD, reflecting endothelial dysfunction.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Endothelial Function

Background:

  • Peripheral Arterial Disease (PAD) is common and often underdiagnosed.
  • Soluble CD146 (sCD146) is linked to endothelial dysfunction and vascular congestion.

Purpose of the Study:

  • To investigate soluble CD146 (sCD146) as a potential novel biomarker for Peripheral Arterial Disease (PAD).
  • To assess the association between plasma sCD146 levels and PAD occurrence and severity.

Main Methods:

  • A case-control study compared 184 symptomatic PAD patients with 163 healthy controls.
  • PAD diagnosis was confirmed via ankle-brachial index (ABI) and imaging.
  • Plasma sCD146 levels were measured using ELISA, with associations analyzed via multivariable logistic regression.

Main Results:

  • sCD146 levels were significantly lower in PAD patients (288 ng/mL) compared to controls (480 ng/mL).
  • Each 10 ng/mL decrease in sCD146 increased PAD odds by 1.25 (OR, 95% CI 1.14-1.36).
  • sCD146 levels did not correlate with PAD severity but showed an inverse relationship with HDL-C in PAD patients.

Conclusions:

  • Lower plasma sCD146 concentration is independently associated with PAD.
  • The findings suggest sCD146 may indicate impaired endothelial homeostasis and metabolic issues in PAD.
  • sCD146 shows potential as a diagnostic biomarker for Peripheral Arterial Disease.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...